Competitive blocking of LRP4–sclerostin binding interface strongly promotes bone anabolic functions
- 31 January 2022
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (2) , 1-12
Abstract
Induction of bone formation by Wnt ligands is inhibited when sclerostin (Scl), an osteocyte-produced antagonist, binds to its receptors, the low-density lipoprotein receptor-related proteins 5 or 6 (LRP5/6). Recently, it was shown that enhanced inhibition is achieved by Scl binding to the co-receptor LRP4. However, it is not clear if the binding of Scl to LRP4 facilitates Scl binding to LRP5/6 or inhibits the Wnt pathway in an LRP5/6-independent manner. Here, using the yeast display system, we demonstrate that Scl exhibits a stronger binding affinity for LRP4 than for LRP6. Moreover, we found stronger Scl binding to LRP6 in the presence of LRP4. We further show that a Scl mutant (SclN93A), which tightly binds LRP4 but not LRP6, does not inhibit the Wnt pathway on its own. We demonstrate that SclN93A competes with Scl for a common binding site on LRP4 and antagonizes Scl inhibition of the Wnt signaling pathway in osteoblasts in vitro. Finally, we demonstrate that 2 weeks of bi-weekly subcutaneous injections of SclN93A fused to the fragment crystallizable (Fc) domain of immunoglobulin (SclN93AFc), which retains the antagonistic activity of the mutant, significantly increases bone formation rate and enhances trabecular volumetric bone fraction, trabecular number, and bone length in developing mice. Our data show that LRP4 serves as an anchor that facilitates Scl–LRP6 binding and that inhibition of the Wnt pathway by Scl depends on its prior binding to LRP4. We further provide evidence that compounds that inhibit Scl–LRP4 interactions offer a potential strategy to promote anabolic bone functions.Keywords
Funding Information
- Israel Science Foundation (357/18, 1615/19)
This publication has 94 references indexed in Scilit:
- Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling InhibitionPLOS ONE, 2013
- Both LRP5 and LRP6 Receptors Are Required to Respond to Physiological Wnt Ligands in Mammary Epithelial Cells and FibroblastsJournal of Biological Chemistry, 2012
- Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loadingBone, 2012
- Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator FunctionJournal of Biological Chemistry, 2011
- Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)European Journal of Human Genetics, 2011
- Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling PathwaysJournal of Biological Chemistry, 2010
- Hepatitis B Virus Induces Expression of Antioxidant Response Element-regulated Genes by Activation of Nrf2Journal of Biological Chemistry, 2010
- High Resolution NMR-based Model for the Structure of a scFv-IL-1β ComplexJournal of Biological Chemistry, 2009
- Characterization of the Structural Features and Interactions of SclerostinJournal of Biological Chemistry, 2009
- LRP4 Serves as a Coreceptor of AgrinNeuron, 2008